IL111544A0 - 6-oxo-nucleosides useful as immunosuppressants - Google Patents
6-oxo-nucleosides useful as immunosuppressantsInfo
- Publication number
- IL111544A0 IL111544A0 IL11154494A IL11154494A IL111544A0 IL 111544 A0 IL111544 A0 IL 111544A0 IL 11154494 A IL11154494 A IL 11154494A IL 11154494 A IL11154494 A IL 11154494A IL 111544 A0 IL111544 A0 IL 111544A0
- Authority
- IL
- Israel
- Prior art keywords
- immunosuppressants
- oxo
- nucleosides useful
- nucleosides
- useful
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Reproductive Health (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15108893A | 1993-11-12 | 1993-11-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL111544A0 true IL111544A0 (en) | 1995-01-24 |
Family
ID=22537266
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL11154494A IL111544A0 (en) | 1993-11-12 | 1994-11-07 | 6-oxo-nucleosides useful as immunosuppressants |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0728134A1 (sv) |
JP (1) | JPH09509397A (sv) |
KR (1) | KR960705825A (sv) |
CN (1) | CN1137274A (sv) |
AU (1) | AU677732B2 (sv) |
CA (1) | CA2175897A1 (sv) |
FI (1) | FI962010A (sv) |
HU (1) | HUT74989A (sv) |
IL (1) | IL111544A0 (sv) |
NO (1) | NO961901L (sv) |
WO (1) | WO1995013277A1 (sv) |
ZA (1) | ZA948591B (sv) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU717160B2 (en) * | 1994-06-22 | 2000-03-16 | Shire Canada Inc. | Novel substituted purinyl derivatives with immunomodulating activity |
US5994361A (en) * | 1994-06-22 | 1999-11-30 | Biochem Pharma | Substituted purinyl derivatives with immunomodulating activity |
US6859652B2 (en) | 2000-08-02 | 2005-02-22 | Mobile Satellite Ventures, Lp | Integrated or autonomous system and method of satellite-terrestrial frequency reuse using signal attenuation and/or blockage, dynamic assignment of frequencies and/or hysteresis |
US20110104186A1 (en) | 2004-06-24 | 2011-05-05 | Nicholas Valiante | Small molecule immunopotentiators and assays for their detection |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN164556B (sv) * | 1986-03-06 | 1989-04-08 | Takeda Chemical Industries Ltd | |
IT1229531B (it) * | 1988-01-20 | 1991-09-04 | Univ Minnesota | Composti nucleosidi dideossidideidrocarbociclici e formulazione farmaceutica che li contiene |
AU647822B2 (en) * | 1990-09-14 | 1994-03-31 | Marion Merrell Dow Inc. | Novel carbocyclic adenosine analogs useful as immunosuppressants |
-
1994
- 1994-10-13 HU HU9601262A patent/HUT74989A/hu unknown
- 1994-10-13 KR KR1019960702453A patent/KR960705825A/ko not_active Application Discontinuation
- 1994-10-13 AU AU81207/94A patent/AU677732B2/en not_active Expired - Fee Related
- 1994-10-13 CA CA002175897A patent/CA2175897A1/en not_active Abandoned
- 1994-10-13 JP JP7513835A patent/JPH09509397A/ja active Pending
- 1994-10-13 CN CN94194463A patent/CN1137274A/zh active Pending
- 1994-10-13 EP EP95900365A patent/EP0728134A1/en not_active Withdrawn
- 1994-10-13 WO PCT/US1994/011778 patent/WO1995013277A1/en not_active Application Discontinuation
- 1994-11-01 ZA ZA948591A patent/ZA948591B/xx unknown
- 1994-11-07 IL IL11154494A patent/IL111544A0/xx unknown
-
1996
- 1996-05-10 FI FI962010A patent/FI962010A/sv not_active Application Discontinuation
- 1996-05-10 NO NO961901A patent/NO961901L/no unknown
Also Published As
Publication number | Publication date |
---|---|
FI962010A (sv) | 1996-07-10 |
HU9601262D0 (en) | 1996-07-29 |
WO1995013277A1 (en) | 1995-05-18 |
NO961901L (no) | 1996-07-11 |
AU8120794A (en) | 1995-05-29 |
ZA948591B (en) | 1995-06-23 |
NO961901D0 (no) | 1996-05-10 |
CN1137274A (zh) | 1996-12-04 |
HUT74989A (en) | 1997-03-28 |
KR960705825A (ko) | 1996-11-08 |
CA2175897A1 (en) | 1995-05-18 |
FI962010A0 (sv) | 1996-05-10 |
AU677732B2 (en) | 1997-05-01 |
EP0728134A1 (en) | 1996-08-28 |
JPH09509397A (ja) | 1997-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69433664D1 (en) | Foetal-sensor | |
DE69400639D1 (en) | Rehydratationsgetraenk | |
DE69426415D1 (en) | Intrapulmonares hormonabgabesystem | |
DE69421914D1 (en) | Ekg-sensor | |
DE69401926D1 (en) | Hydroxamsäurederivate | |
DE69406448D1 (en) | Luftreinigungsgerät | |
DE69405713D1 (en) | Carbonylierungsverfahren | |
HU9600805D0 (en) | Polyazacycloalkanes as dichelants | |
DE69412242D1 (en) | Orthopädisches gussmaterial | |
DE59407177D1 (en) | 2-fluorcycloyhexen-derivate | |
DE69423875D1 (en) | Hydrodealkylierungsverfahren | |
DE69429512D1 (en) | Thermoresistente alpha-1-antitrypsinmütante | |
DE59409705D1 (en) | 3-methoxy-2-phenyl-acrylsäuremethylester | |
GB2274735B (en) | Membraphone | |
DE59408733D1 (en) | Metallhalogenidentladungslampe | |
DE59410065D1 (en) | 3-methoxy-2-phenyl-acrylsäuremethylester | |
HU9601262D0 (en) | 6-oxo-nucleosides useful as immunosuppressants | |
DE69407946D1 (en) | Oxychlorierungskatalysator | |
GB2274048B (en) | Headcollars | |
DE69425743D1 (en) | Faserreaktive anthrachinon-farbstoffe | |
DE69422299D1 (en) | Photographisches reproduktionsgerät | |
DE69412128D1 (en) | Kühlcontainer | |
DE69413832D1 (en) | Amidierungskatalysatorkonzentrat | |
GB2275632B (en) | Thread-drill | |
ZA94961B (en) | 15-oxasterols as hypocholesterolemics |